Abstract
p66shc, a member of the ShcA protein family, is essential for cellular response to oxidative stress, and elicits the formation of mitochondrial Reactive Oxygen Species (ROS), thus promoting vasomotor dysfunction and inflammation. Accordingly, mice lacking the p66 isoform display increased resistance to oxidative tissue damage and to cardiovascular disorders. Oxidative stress also contributes to noise-induced hearing loss (NIHL); we found that p66shc expression and serine phosphorylation were induced following noise exposure in the rat cochlea, together with markers of oxidative stress, inflammation and ischemia as indicated by the levels of the hypoxic inducible factor (HIF) and the vascular endothelial growth factor (VEGF) in the highly vascularised cochlear lateral region and spiral ganglion. Importantly, p66shc knock-out (p66 KO) 126 SvEv adult mice were less vulnerable to acoustic trauma with respect to wild type controls, as shown by preserved auditory function and by remarkably lower levels of oxidative stress and ischemia markers. Of note, decline of auditory function observed in 12 month old WT controls was markedly attenuated in p66KO mice consistent with delayed inner ear senescence. Collectively, we have identified a pivotal role for p66shc -induced vascular dysfunction in a common pathogenic cascade shared by noise-induced and age-related hearing loss.
Sensory neural hearing loss by exposure to noise or ototoxic drugs and age related hearing loss (ARHL) are the most common pathologies of the inner ear, which impair significantly the quality of life. Reactive Oxygen Species (ROS) are recognized as major contributors to the onset and progression of these communication disorders. In particular, the main underlying molecular mechanisms include free-radical formation and oxidative stress, however, reduced cochlear blood flow and inflammation have also emerged as key processes in recent years1,2,3,4. Oxidative stress results from an imbalance between ROS production and the cellular antioxidant defense system. This condition represents the main mechanism of cochlear damage following noise over-exposure and ARHL3,5, beside representing the leading pathway of several neurodegenerative diseases6. Under stress conditions, ROS levels increase and, because of their high reactivity, participate in a variety of chemical reactions leading to cell damage, necrosis, and apoptosis via oxidation of lipids, proteins, and DNA7. Mitochondria are generally considered to be the primary source of ROS as well as the major target for their damaging effects8,9. With this respect, several studies have revealed the role of the p66shc adaptor protein in ROS production within the mitochondria and its involvement in various oxidant-related pathologies10,11,12. Normally p66shc resides in the cytosol, while under oxidative stress (e.g., under ischemia/reperfusion insult), it is translocated trough a PKC-dependent mechanism in the mitochondria where it serves as an important source of ROS. In mitochondria, this adapter molecule has been suggested to function as a redox enzyme possibly oxidizing cytochrome c and generating H2O2 through its amino-terminal portion that displays sequence similarity with certain redox enzymes13,14,15. Accordingly, in cells lacking the p66 gene, free radicals are reduced and tolerance to oxidative stress is increased; moreover, knock-out mice lacking the p66shc gene survive acute exposure to the radical generator Paraquat10, and, in agreement with the “free radical theory of ageing”, are resistant to several age-related diseases, including obesity16,17, atherosclerosis18,19, ischemic injury20,21, and diabetes17,22. Importantly, much of the detrimental and ageing-accelerating activity of p66shc appears to involve the (micro and macro) vasculature, where p66-dependent ROS (as in the context of diabetic hyperglycemia) promote endothelial damage and dysfunction by reducing nitric oxide (NO) bioavailability, compromising vasomotor function and participating in proinflammatory cascades that lead to endothelium activation and enhanced leukocyte adhesion and atherogenesis23,24.
Cochlea hosts a complex vascular organization, comprising at least two distinct capillary networks located, respectively, within the Spiral ganglion (SGNs) and the stria vascularis (StV). In particular the capillaries of the StV form a blood-labyrinth barrier that regulates ion transport and fluid balance in the inner ear and is crucial for maintaining the endocochlear potential and by extension the sensory hair cell function25,26,27,28. Accordingly, vasculature-centered pathologic processes such as reduced blood flow, hypoxia and inflammation contribute to hearing impairment following acoustic trauma and most likely also to strial presbycusis29,30,31
The emerging role of p66shc in age-related disorders associated with increased levels of oxidative stress and vascular/endothelial dysfunction, along with the strong mechanistic commonalities between hearing impairment occurring with age and auditory defects by acoustic trauma or chemical toxicity, prompted us to investigate the potential involvement of p66shc in noise-induced hearing loss (NIHL) in the rat. By a combination of functional, morphological and biochemical studies, and taking advantage of the availability of a p66 deficient mouse strain, we collected here evidence for a novel p66shc-centered pathogenic pathway in NIHL involving cochlear oxidative stress, inflammation and impaired blood flow, the latter revealed by a robust hypoxic/angiogenic response. These findings, while provide ground for novel preventive and therapeutic approaches against common forms of hearing loss, add NIHL and ARHL to the list of p66shc-related disorders, likely through the same vascular mechanisms that reportedly underlie p66shc roles in ischemic, atherosclerotic and diabetic vascular damage and in whole organism senescence23.
Results
Noise-induced hearing loss is accompanied by oxidative stress and by induction and phosphorylation of p66shc in the rat cochlea
In order to confirm the role of oxidative stress in NIHL and to gain initial insight in the potential role of p66shc in this process we subjected Wistar rats to a paradigm of acoustic insult that models NIHL32,33. We recorded ABRs (Auditory Brainstem Responses) before and 1, 3, 7 and 21 days after noise exposure; in this experimental setting, loss of auditory function was quantified as threshold shift, i.e. the difference between the pre-noise and post-noise exposure value of auditory threshold for a given frequency. In noise-exposed rats (Fig. 1A), at day 1 after acoustic trauma the temporary threshold shift was elevated of about 30–40 dB for mid and high frequencies and of 15 dB for the low frequencies, with the greatest hearing loss occurring in the 12–24 kHz range (Fig. 1B). Three days after acoustic trauma, there was a small partial recovery in the Noise group and the average of threshold shift decreased approximately of 5 dB for all frequencies. At day 7, an additional 10 dB recovery of thresholds was detected involving all frequencies with a greater attenuation in the mid and high frequency range. At day 21 measurement, thresholds continued to recover; however, as previously reported32,33, noise-exposed rats showed a residual permanent threshold shift of about 10–25 dB for low and mid/high frequencies respectively, (Fig. 1A).
To further characterize the functional effect of exposure to noise, we studied the latency/intensity and amplitude/intensity curves of ABR waveforms at 16 kHz. The ABR latency provides insight on the transmission times along the auditory pathway, whereas ABR amplitude is a function of neural synchrony and of the number of neural units firing; their analyses can therefore provide diagnostic information on these neural functions. Evaluations of ABR P1 wave at day 1 (Fig. 1C) showed increased latency and decreased amplitude, consistent with significant impairment of the auditory function at this early time point after acoustic trauma.
Based on the above findings, we used the lipid peroxidation marker 8-isoprostane and the superoxide marker DHE (Dihydroethidium) to evaluate the levels of oxidative stress in the cochlea (HCs, SGNs and stria vascularis, Fig. 1D) 24 h after noise exposure (Fig. 1E–H), coincident with the maximum auditory defect. As shown in Fig. 1E,G, 8-isoprostane and DHE signals, barely detectable in the unexposed cochleae, became intense in all cochlear regions in noise-exposed animals (Fig. 1F,H and optical density in Fig. 1I), consistent with accumulation of ROS and oxidative damage in these structures.
In order to establish an initial correlation between noise-induced cochlear oxidative stress and p66shc we immunostained inner ear sections isolated after 24 hours of noise exposure or sham treatment for p66shc (Fig. 1J,K) or its ser-36 phosphorylated form (ser36-P-p66shc) (Fig. 1L,M). Immunofluorescence analysis displayed a faint staining for p66shc (Fig. 1J and optical density in Fig. 1N) in the untreated group and a strong signal increase in the cochlea of exposed animals, in particular in the stria vascularis and SG (Fig. 1K). Overlapping results were obtained with ser36-P-p66, whose intensity and distribution mirrored that of total p66shc (Fig. 1L,M and optical density in Fig. 1O). Accumulation of phosphorylated (i.e. active) p66shc in the cochlea was also confirmed by phospho-specific western blot analysis of bulk cochlear homogenates using an anti phospho ser36-p66shc specific antiserum (Fig. 1P). Band quantification, in particular, revealed for ser-36-p66 an increment of about 30% (p < 0.05 by two-tailed t-test) in Noise group compared to control rats (Fig. 1Q). Collectively, these findings indicate that p66shc is expressed in the rat cochlea and is induced and phosphorylated in response to an acoustic trauma, in a fashion that parallels significant auditory loss and the establishment of intense oxidative stress.
NIHL and oxidative stress are ameliorated in p66shc deficient mice
To establish a mechanistic connection between p66shc induction by noise and NIHL, we subjected wild type 129Sv mice and p66-deficient (p66KO) mice10 to acoustic trauma and evaluated ABRs at different times as described for rats. Like in rats, the greatest hearing loss occurred in the mid-high frequencies range (12–24 kHz). The baseline ABR thresholds (day 0) did not differ among the assigned treatment groups (data not shown). At day 1 after noise exposure, the threshold shift in WT mice was of about 40–60 dB for mid and high frequencies and of 20 dB for the low frequencies, with the highest threshold shift being observed at 16 kHz (p < 0.0001) (Fig. 2A). Interestingly p66KO animals recorded at the same day appeared remarkably resistant to noise, with an elevation of threshold of only about 15–25 dB across all frequencies (Fig. 2B). At 3 and 7 days after noise exposure a prompt recovery of 30–40 dB of threshold was detected in WT animals at all frequencies, with a greater attenuation in the mid and high frequency range. At day 21 measurement, thresholds continued to recover to reach a permanent shift value of about 5–10 dB for low, mid and high frequencies (Fig. 2A). Differences between WT and p66KO mice, evident at day 1 (Fig. 1C), become progressively smaller over later measurements, with threshold shift curves superimposable to WT controls at 7 and 21 days and a very similar (5–10 dB) threshold shift (Fig. 2A,B). Evaluation of ABR P1 wave at day 1 (Fig. 2D) showed increased latency and decreased amplitude in WT mice but not in KO, in keeping with the above evidence of preserved auditory function after noise exposure in the latter mutant strain.
Prompted by these findings, we compared the two strains for the levels of cochlear oxidative stress 24 h after noise exposure. As shown in Fig. 2E–L, 8-isoprostane staining and DHE signal, barely detectable in the unexposed cochleae, became intense in all cochlear structures in noise-exposed wild type animals (Fig. 2F,J). However, in keeping with functional data, fluorescence increase was markedly attenuated in p66KO exposed mice (Fig. 2H,L), suggesting that p66shc is required, to a large extent, for the long reported noise-induced cochlear oxidative damage.
Consistent with these findings, and with similar evidence in rats, immunofluorescence analysis of cochlear sections from wild type mice confirmed a strong induction of both p66shc (Fig. 2M,N) and ser36-P-p66shc (Fig. 2Q,R), especially in the stria vascularis and Spiral ganglion, 24 hours after noise exposure. Importantly, this signal was specifically attributable to p66shc, as confirmed by lack of reactivity to either antiserum in the cochleae of Ctrl (Fig. 2O,S) and Noise p66 KO animals (Fig. 2P,T). The immunofluorescence data were confirmed by optical density analyses both for 8-isoprostane and superoxide (Fig. 2U) and for p66shc and ser36-P-p66shc (Fig. 2V,W) level.
Noise induces a proinflammatory and proangiogenic response in rat cochlea
Inflammation participates in noise-induced hearing loss1,2; moreover, inflammation is a common consequence of tissue oxidative damage, and evidence exist that lack of p66shc may protect tissues, at least in part, by reducing damage-associated inflammation34,35. To obtain a snapshot of the inflammatory cytokines and factors released in the cochlea in response to acute noise injury, cochlear homogenates from sham-and noise-treated rats were interrogated for the expression of multiple inflammatory mediators by means of a commercial cytokine array.
Of the 34 factors tested, only 3 (INF gamma, Interleukin 1 alpha, and VEGF) displayed a fold increase >1.5 in the noise-exposed sample; conversely, the Ciliary Neurotrophic Factor (CNTF), a trophic molecule potentially implicated in age-related hearing loss36, was markedly decreased (2 fold reduction) by noise (Fig. 3). Similarly decreased was the content of Interleukin 10, a cytokine broadly recognized “anti-inflammatory” or inflammation-terminating functions37. Overall, this analysis provided evidence for an early proinflammatory and angiogenic cochlear response to acute acoustic trauma, to be further investigated in the context of p66shc deficiency.
p66shc contributes to cochlear ischemic/angiogenic response to noise
Prompted by the presence of VEGF-A among the cochlear cytokines induced by noise, and in order to identify the cochlear structures expressing VEGF-A, a series of immunofluorescence studies were performed in rats (Ctrl and Noise-exposed Fig. 4A,B,G,H) and in WT and p66KO mice (Ctrl and Noise-exposed, Fig. 4C–F,I–L) 24 h after the acoustic insult. In agreement with biochemical analysis of rat cochlear homogenates, noise exposure strikingly increased VEGF-A immunoreactivity in all cochlear structures, the stria vascularis displaying, as expected for an angiogenic factor, the most evident changes (Fig. 4B,H). Importantly, these changes were blunted in the cochleae of p66KO compared to WT mice (Fig. 4D,J,F,L). Quantitative analysis of fluorescence intensity in the stria vascularis and SG confirmed that VEGF-A immunostaining is significantly increased by noise both in rat and mouse cochlea, in a fashion that requires p66shc and is markedly reduced in p66KO animals (Fig. 4M,N1 and N2).
Since noise insult reportedly compromises cochlear microcirculation38,39, and VEGF expression often occurs in response to tissue ischemia/hypoxia through transcriptional upregulation by the hypoxia induced factor 1 alpha (HIF-1α)40, we also evaluated, at the same time point, the expression of both VEGF-A and the latter hypoxic marker in cochlear sections in rats before and 24 h after acoustic trauma (Fig. 4O–T, StV; Fig. 4U–Z, SGNs). As expected, HIF-1α was nearly undetectable in the cochlea of sham-treated animals (Fig. 4P,V); remarkably, however, noise exposure led to a strong increase of HIF-1α immunoreactivity in stria vascularis and spiral ganglion neurons (Fig. 4S,Y), specifically in both nuclei and cytosol as shown by Z-stack confocal analyses (Fig. 4S1,Y1). Interestingly, confocal analysis of sections simultaneously stained for HIF-1α and VEGF-A (Fig. 4Q,T,W,Z) confirmed that the expression patterns of these two protein species largely overlap in noise-exposed samples (compare in Fig. 4Q,W with T,Z), suggesting that they belong to the same hypoxic signaling cascade triggered, in highly vascularized areas of the cochlea, by p66shc-dependent oxidative stress and microvascular dysfunction.
Delayed ARHL in p66KO mice
Cochlear oxidative damage, inflammation and impaired blood flow are also typical features of age-related inner ear degeneration leading to presbycusis30,41,42. Since p66shc deletion delays several features of ageing in mice, we asked whether p66KO animals could be protected by ARHL as well as by NIHL. To answer this question we performed ABR threshold measurements in WT and p66KO mice at 2, 7, 12 and 24 month old. WT and p66KO mice of age 2 and 7 month had the same threshold value across the analyzed frequencies (about 50 dB at 6 kHz and about 30–35 dB in mid-high frequencies) while, 12 month-old WT mice had significantly higher threshold values (65–70 dB across frequencies, Fig. 5A) compared to younger animals. Such time-dependent decline of auditory function was however attenuated in p66KO mice of the same age, that displayed threshold values 15–30 dB lower than WT controls, with the highest difference (42% amelioration) observed at 16 kHz (Fig. 5B). 24 month-old mice displayed a further increase in ABR thresholds (up to 80–90 dB across frequencies), with no longer difference between the WT and p66KO strains (Fig. 5A).
We further analyzed ABR waves by studying the latency/intensity and amplitude/intensity curves of ABR waveforms at 16 kHz in 7, 12 and 24 month old mice (shown in Fig. 5C,D for P1 wave). In keeping with threshold analysis, the WT latency at 12 month age was prolonged about ~1 ms for P1 as compared to p66KO mice (Fig. 5C). The WT amplitude rapidly declined with age, and, at 12 month age, was lower about ~300 nV for P1 as compared to p66KO, in which amplitude values did not significantly change compared to 7 months (Fig. 5D). However, at 24 month age there was no amplitude difference between WT and p66KO mice (Fig. 5D). These findings suggest an impairment of neural synchrony and/or a decrease in the number of neural unit firing during ageing that is similar to that observed in noise-exposed animals43 as shown in Figs 1 and 2. More important, they confirm that p66shc deletion delays (but does not prevent) the age-dependent decline of auditory function in 129SvEv mice, possibly by impinging on the same oxidative and circulatory mechanisms that also underlie NIHL.
Discussion
The main findings of the present study are that: a) p66shc is expressed in multiple structures of rodent (mouse and rat) cochlea, and its levels of expression/phosphorylation are increased, especially in the stria vascularis and spiral ganglion, 24 hours after the acoustic insult; b) 129SvEv mice lacking the p66shc adapter protein are resistant to the transient impairment of auditory function induced by noise in their p66shc-proficient controls; c) the acute noise-induced hearing loss is accompanied, in rats and mice, by histochemical and biochemical signs of oxidative stress, inflammation and compromised cochlear blood flow, which are absent or attenuated in p66-deficient mice; d) the absence of p66shc delays the onset of auditory decline in 129Sv mice, a strain affected by progressive ARHL. Collectively, these evidences support a pivotal role for p66shc in a pathogenic cascade shared by two common and invalidating auditory disorders, and involving, as key components, oxidative stress and vascular/endothelial dysfunction.
We have compared wild type and p66−/− (p66shcKO) mice, both in the 129SvEv background. The interest in this specific strain was also linked to the peculiar susceptibility of 129SvEv mice to NIHL versus ARHL. Consistent with literature44,45, we found that the 129SvEv animals were remarkably noise resistant; surprisingly, however, we observed in WT mice, but not in p66KO animals, a narrow window of vulnerability to noise exposure during the first 24 hours following acoustic insult. In wild type mice, as well as in Wistar rats, the hearing deficit was associated with evidence of oxidative stress and with increased expression of both p66shc and ser-36-P-p66 in the stria vascularis, organ of Corti and spiral ganglion neurons. These data underlined a role of p66shc in the initial acute phase of noise-induced cochlear damage even in animals showing a resistance to noise as determined, at later time points, by normal threshold values at ABR analysis and absence of oxidative stress.
The transient nature of the auditory defect observed in WT animals 24 hours after noise exposure likely reflects a short-term functional imbalance rather than a structural damage resulting for instance, from death of hairy cells46,47 or loss of fibrocytes in the lateral wall48,49. We propose that such a functional defect resides in the establishment of p66shc- and ROS-triggered endothelial dysfunction and in (transiently) compromised cochlear blood flow. This idea is consistent with evidence of ROS increase and of p66shc accumulation and phosphorylation especially in the stria vascularis, a highly vascularized region of the cochlea whose capillary network underlies the blood-labyrinth barrier and participates in the ion fluxes that maintain endocochlear potential and by extension neurosensory excitability26,27. Moreover, induction in rats of inflammatory markers (like interleukin 1 alpha) known to elicit endothelial activation, and evidence in both rats and mice of elevated VEGF levels following noise exposure are consistent with endothelial stress and reduced blood flow leading to cochlear hypoxia31,50. This is further corroborated by immunofluorescence detection in the rat cochlea of accumulated Hypoxia Induced Factor (HIF-1α), a master transcriptional regulator of tissue hypoxic response which includes upregulation of VEGF40. A role of p66shc in vascular homeostasis and in particular in (micro- and macro-) vascular disorders associated with oxidative stress has been convincingly demonstrated51. Importantly, these disorders are typical of ageing-associated diseases like atherosclerosis and diabetic complications23. In a current model, p66-triggered mitochondrial ROS reduce NO bioavailability and produce highly reactive peroxynitrite, leading to impaired vasorelaxation, accumulation of oxidative damage and vascular inflammation, that further contributes to decreased blood flow. Our findings, including blunted oxidative stress and reduced (although not abrogated) VEGF levels in noise-exposed p66KO mice, clearly suggest that p66shc may be responsible of a robust albeit transient phenomenon of cochlear vascular dysfunction that dramatically impairs auditory function few hours after noise exposure in p66shc proficient animals.
We have also observed that p66 deletion delays the age-related auditory decline of 129SvEv, mice, with the maximum difference between p66-decifient animals and controls being evident at twelve month age. ARHL has been previously linked to disturbances of cochlear blood flow and to inflammatory changes of the cochlea30,38,39. Therefore, although cochleae have not been analyzed in the context of the ARHL experiments, it is conceivable that, like in other models of age-related disease, beneficial effects of p66shc ablation on ARHL reflect, at least in part, a better preserved vascular function. Thus, the same p66shc-centered pathogenic circuitry involving oxidative stress, vascular dysfunction with inflammatory changes and cochlear ischemia may underlie both NIHL and ARHL in 129SvEv mice. Noteworthy, literature evidence and our own data indicate that this mouse strain displays a remarkable resistance to noise-induced permanent hearing loss44,45. Thus, the transient/temporary auditory loss that we were able to detect in a very narrow temporal window of sensitivity after trauma, may represent a specific component of NIHL that shares its pathogenic mechanism (i.e. vascular dysfunction) with ARHL, to which these mice are instead prone44.
Finally, the bulk of data from the murine and rat model connects p66shc action to biochemical evidence of inflammation. This emerging connection is particularly intriguing. In fact, a low grade chronic inflammatory reaction (parainflammation) is believed to underlie most age-related pathologic processes52 including ARHL41,53; our findings, while standing for a shared oxidative-inflammatory axis in NIHL and ARHL, suggest that the activation of such axis, beside or in the context of vascular dysfunction, may represent a common event downstream of p66shc and by extension a general link between p66shc, systemic ageing and reduced health-span. This attractive hypothesis deserves further validation in additional models of age-related disease and “inflammaging”54.
Materials and Methods
Chemicals
Common laboratory chemicals were from SIGMA, unless differently stated. Antibodies used are listed below in methods where appropriate.
Animals
Male Wistar rats with normal Preyer’s reflex and male mice SvEv129 p66shcA+/+ wild-type and p66shcA−/− (henceforth indicated as WT and p66KO respectively) were included in this study. To investigate NIHL we used two month old Wistar rats and two month old mice randomly divided into the following: A) rat control, animals that did not received any treatment (Ctrl n = 20); B) rat noise, animals exposed to acoustic trauma (Noise n = 26); C) WT control, animals that did not received any treatment (WT Ctrl n = 10); D) WT noise, animals exposed to acoustic trauma (WT Noise n = 16); E) p66KO control, animals that did not receive any treatment (p66KOCtrl n = 10); F) p66 KO noise, animals exposed to acoustic trauma (p66KO Noise n = 16). We also analyzed the trend of hearing loss in ARHL and we used WT and p66 KO mice at age 2, 7, 12 and 24 months (8 animals x group).
All efforts were made to minimize animal suffering and to reduce the number needed for the experiments in accordance with the European Community Council Directive of November 24, 1986 (86/609/EEC). All procedures were performed in compliance with the Laboratory of Animal Care and Use Committee of the Catholic University, School of Medicine of Rome and were approved by the Italian Department of Health.
Auditory brainstem response (ABR) recordings
ABR recordings were performed to analyze the summed responses of the synchronous firing of auditory nerve fibers and auditory brainstem neurons. Before ABR recordings, the animals were mildly anesthetized (ketamine at 35 mg/kg and medetomidine at 0.25 mg/kg for rats; ketamine at 35 mg/kg and medetomidine at 0.5 mg/kg for mice) and placed in the anechoic room. Three stainless steel recording electrodes were subcutaneously inserted posterior to the tested pinna, vertex and contralateral pinna. ABRs were collected using a computer-controlled TDT System 3 (Tucker-Davis Technologies, Alachua, FL, USA) data acquisition system with real-time digital signal processing. Tone bursts ranging from 6 to 32 kHz (rise/fall time, 2 ms; total duration, 2 ms; repetition rate, 21/s) were presented monaurally in an open field using a horn tweeter (Tucker-Davis Technologies). The responses were filtered (100–3000 Hz bandpass), digitized and averaged across 500 discrete samples at each frequency-level combination. ABRs were measured at 6–32 kHz frequencies for both species. ABRs were assessed bilaterally in all animals (mice and rats) to ensure normal hearing. ABRs were reassessed in NIHL-exposed animals at several time points (1, 3, 7 and 21 days) to evaluate the effect of noise and in aging mice (2, 7, 12 and 24 months) to monitor the age-dependent auditory decline. Thresholds were determined by decreasing tone intensity in 5 dB steps starting at 100 dB and decreasing to 0 dB or until a reliably scored ABR component was detected. Then, an ascending series of ABRs was gathered starting below this point and moving up in stimulus intensity55,56. Hearing loss was estimated by comparing ABR thresholds, recorded in the animals at day 0 (before the acoustic trauma), with ABR thresholds at the different time points (1, 3, 7 and 21 days) after the noise exposure. Thus, the ABR data are expressed in terms of threshold and threshold shift that represents the difference between the pre-noise and post-noise exposure values of each animal for NIHL experimental procedure for each group. In ARHL experiments, thresholds were compared during the aging period.
ABR Latencies-Amplitude (Neural Transmission Times)
ABR analysis for the study of latency and amplitude was performed in rats and mice used for NIHL study and in mice used for the ARHL experimental procedure (WT and p66KO). The rodents ABR is composed of four components (labeled from P1 to P4). These components reflect the neural activity chiefly from the auditory nerve (Fetoni et al.43). We analyzed the ABR waves at 6–32 kHz however, latency–intensity (L–I) and amplitude–intensity (A–I) curves were derived at 16 kHz frequency condition because, at this frequency, it is possible to have ABR recordings at the lowest intensity of stimulation. Thus this condition provides the clearest L–I and A–I curves. An experimenter blind to treatment conditions scored the latencies and amplitudes of the ABR waves. Another experimenter then checked the ABR scoring for reliability.
Noise exposure
Wistar rats or WT and p66KO mice were exposed to noise in the NIHL paradigm applying a standardized acoustic trauma model, used in previous papers (35;36). Rats were deeply anesthetized, placed in a sound-proof room and exposed for 60 min to a 120 dB SPL pure tone sound at a frequency of 10 kHz. The sound was symmetrically presented in open field by a two dome tweeter (TW340 × 0, Audax) positioned 10 cm in front of the animal’s head55,56. Mice were placed in the anechoic room and exposed to a 100 dB sound pressure level SPL for 90 min at 10 kHz. The sound was presented in an open field by a dome tweeter (TW340 × 0; Audax, Chateau du Loir, France) positioned at the center of the cage. The sound was generated and amplified as previously described in Fetoni et al. 2014.
Immunohistochemistry and double-labeling immunofluorescence
To assess noise-induced oxidative stress we used 8-isoprostane immunostaining and Dihydroethidium (DHE) staining. p66shc involvement in NIHL was analyzed by anti p66shc and anti ser36-P-p66shc laboratory antibodies listed below. The animals of NIHL procedure were ABR tested before and 24 hours after noise exposure and then anesthetized and sacrificed with a lethal dose. The cochleae were quickly removed, and the samples were fixed with 4% paraformaldehyde in PBS at 4 °C and a pH 7,5. Next, the cochleae were decalcified in 10% Ethylenediaminetetraacetic acid (EDTA) incubated for 48 h in 30% sucrose, embedded in OCT, and cryosectioned at a thickness of 6 μm for mice and 12 μm for rats (Cryostat CM 1950; SLEE, Nikon, TO Italy). For superoxide detection the cochlear specimens were incubated with 1 μM DHE (Invitrogen D23107, Carlsbad, CA, USA) in PBS for 30 min at 37 °C and then coverslipped with an antifade medium (ProLong Gold, Invitrogen P36930). For the immunofluorescence analyses, the slides were incubated in a blocking solution containing 1% BSA, 0.5% Triton X-100, and 10% normal goat serum in PBS for 1 h at room temperature and then incubated overnight at 4 °C with a solution containing primary antibodies (mouse monoclonal anti-p66shc [LifeSpan Bioscience, WA, USA]), anti ser36-P-p66shc [Clone 6E10, Alexis, CA, USA] and anti HIF1α [Novus Bio, CO, USA], all 1:50 dilution in PBS; rabbit polyclonal anti 8-isoprostane [Oxford Biomedical Research, MI, USA] 1:100 and anti-VEGF-A ([Bioss Massachusetts, USA], 1:100 dilution in PBS). These antibodies cross reacted with mouse and rat tissues. At the end of the incubation, all slides were washed twice in PBS and incubated at room temperature for 2 h in the dark with secondary reagents (donkey anti-mouse (Alexa Fluor 546) or goat anti-rabbit (Alexa Fluor 633 or 488, IgG; Invitrogen, MI, Italy) diluted 1:400 in 0.1 M PBS. After another wash in PBS, samples were double stained with DAPI (1:500) for 15 min in the dark at room temperature. Images of anti 8-isoprostane, anti-p66shc, anti ser36-P-p66shc, anti-HIF1α (hypoxia induced factor) and anti-VEGF-A (vascular endothelial growth factor) immuno-labeled specimens were taken by fluorescence microscope (Olympus BX63, MI, Italy) and confocal microscope (TCSSP2, Leica, Germany). For HIF1α confocal Z-stacks, series of 15–20 μm-thick were acquired as images of 1024 × 1024 pixels, reordered at intervals of 0.5 μm, in order to evaluate the real extent of the nuclear and/or cytoplasmatic fluorescence in high magnifications (40×) of SGNs and StV . The optical density analysis was performed to quantify 8-isoprostane, DHE, p66shc, ser36-P-p66shc and VEGF-A fluorescence signals (LCS Lite, Leica Confocal Software)33.
Control experiments were performed by omitting the primary antibody during processing of tissue randomly selected across experimental groups. Staining was absent in the hair cells (HCs) and SGNs, indicating neither spontaneous fluorescence nor non specificity of antibody. Tissues from all groups were always processed together during the procedures to limit variability related to antibody penetration, incubation time, post-sectioning age, and condition of tissue.
Western blot analysis
Cochleae were quickly removed from the skull, the tympanic bulla was exposed, and the bony capsule of the cochlea and the lateral wall tissues were removed under stereomicroscope. The specimens from each group included the modiolus and the organ of Corti. They were collected on ice and stored at −80 °C. The cochleae were rinsed and minced in PBS, put in plastic tubes and disaggregated with a tissue homogenizer in PBS containing protease inhibitor, Homogenates were clarified by centrifugation at 18.500 g and assayed for protein content by a modified Lowry method, using a commercial kit (Priotein DC, BIORAD, MI, Italy) according to the manufacturer’s recommendations. For western blot analysis, equal amounts of protein samples were resolved by SDS–PAGE, and electrotransferred onto nitrocellulose (Protran BA 85, Whatman®, GE Healthcare). Equal protein loading throughout the lanes was verified by reversible Ponceau-S staining. After 2 hours blocking in TBS-T containing 5% w/v dry skim milk, membranes were incubated with the primary reagent (anti ser36-P-p66shc, 1:1000 dilution in TBS-T + 3% dry milk) for 16 hours at 4 °C. Immuno-complexes were visualized by a HRP-conjugates goat anti mouse antiserum followed by ECL detection. Autoradiograms were acquired using a Gel. DOC Imaging Station (BIORAD) equipped with a dedicated Software (QuantityOne), and background-subtracted band intensity quantified by the Image-J software17.
Cytokine assay
Cytokine profiling of rat cochlear homogenates was performed by a commercial cytokine antibody array kit (Rat Cytokine Array C2, RayBiotech, Inc., Norcross, GA, USA), according to manufacturer’s recommendations. Briefly, 1 mg protein homogenate (in 1 ml buffer) was incubated with the array membrane at 4 °C for 16 hours; after 4 washes, the biotinylated antibody cocktail solution was added for 2 hours at RT under continuous rocking. After removal of excess antibody and four additional washes immunocomplexes were visualized by Streptavidin-HRP followed by Enhanced Chemoluminescence and autoradiography. Spots were quantified on digital images by the ImageJ software. Each Spot volume (area x mean intensity) was subtracted of the nearby background signal. For each spot of the array a ratio Noise/Sham was calculated, and ratios were further normalized for the ratio between Positive control spots to account for membrane-to-membrane signal differences. Averages of duplicate spots were calculated, and Ratios >1.5 or <0.66 (1.5 fold reduction) were considered significant.
Statistical analysis
The results are presented as means ± standard deviation (SD) or standard error of the mean (SEM). ABR data were analyzed by means of three-way ANOVA (group/genotype x day x frequency); or two-way ANOVAs (group/genotype x frequency or time point x frequency). Latency and amplitude data were analyzed by means of two-way ANOVAs (group/genotype x decibels). When ANOVA showed significant differences, pair-wise comparisons between means were tested by Tukey’s post hoc testing (Statistica; Statsoft, USA). Western blot data were analyzed using unpaired two-tailed Student’s t-test. In all analyses, p < 0.05 was considered statistically significant.
Additional Information
How to cite this article: Fetoni, A. R. et al. The redox protein p66shc mediates cochlear vascular dysfunction and transient noise-induced hearing loss. Sci. Rep. 6, 25450; doi: 10.1038/srep25450 (2016).
Acknowledgments
The authors wish to thank Prof. Piergiuseppe Pelicci and Dr. Marco Giorgio (European Institute of Oncology, Milan, Italy) for providing p66KO mice and the relative control strain. This work was supported by funds from Università Cattolica (intramural programs D1 and D3.2, 2013) to AR. Fetoni, G. Pani and D.Troiani; from Italian Association for Cancer Research (AIRC, IG 15381) to G. Pani; from the Italian Ministry of Foreign Affairs and International Cooperation (MAECI) to G. Pani. The confocal analysis was performed at the “Labcemi” core facility of the Università Cattolica.
Footnotes
Author Contributions G.P. and D.T. conceived the study and designed experiments; A.R.F. and S.L.M.E. designed experiments and performed ABR studies; F.P. and R.R. performed IHC studies; D.S. performed biochemical studies; G.P., D.T. and Gaetano P. analysed data; G.P. and D.T. wrote the paper; all the authors read and commented the manuscript.
References
- Abi-Hachem R. N., Zine A. & Van De Water T. R. The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies. Recent Pat CNS Drug Discov 5, 147–163 (2010). [DOI] [PubMed] [Google Scholar]
- Fujioka M., Okano H. & Ogawa K. Inflammatory and immune responses in the cochlea: potential therapeutic targets for sensorineural hearing loss. Front Pharmacol 5, 287 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henderson D., Bielefeld E. C., Harris K. C. & Hu B. H. The role of oxidative stress in noise-induced hearing loss. Ear Hear 27, 1–19 (2006). [DOI] [PubMed] [Google Scholar]
- Le Prell C. G., Yamashita D., Minami S. B., Yamasoba T. & Miller J. M. Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hear Res 226, 22–43 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bottger E. C. & Schacht J. The mitochondrion: a perpetrator of acquired hearing loss. Hear Res 303, 12–19 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Halliwell B. & Gutteridge J. M. Lipid peroxidation in brain homogenates: the role of iron and hydroxyl radicals. J Neurochem 69, 1330–1331 (1997). [DOI] [PubMed] [Google Scholar]
- Rigoulet M., Yoboue E. D. & Devin A. Mitochondrial ROS generation and its regulation: mechanisms involved in H2O2 signaling. Antioxid Redox Signal 14, 459–468 (2011). [DOI] [PubMed] [Google Scholar]
- Adam-Vizi V. & Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 27, 639–645 (2006). [DOI] [PubMed] [Google Scholar]
- Lenaz G. Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv Exp Med Biol 942, 93–136 (2012). [DOI] [PubMed] [Google Scholar]
- Migliaccio E. et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309–313 (1999). [DOI] [PubMed] [Google Scholar]
- Migliaccio E., Giorgio M. & Pelicci P. G. Apoptosis and aging: role of p66shc redox protein. Antioxid Redox Signal 8, 600–608 (2006). [DOI] [PubMed] [Google Scholar]
- Berry A. & Cirulli F. The p66Shc gene paves the way for healthspan: evolutionary and mechanistic perspectives. Neurosci Biobehav Rev 37, 790–802 (2013). [DOI] [PubMed] [Google Scholar]
- Giorgio M. et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122, 221–233 (2005). [DOI] [PubMed] [Google Scholar]
- Pinton P. et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 315, 659–663 (2007). [DOI] [PubMed] [Google Scholar]
- Zorov D. B., Juhaszova M. & Sollott S. J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94, 909–950 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berniakovich I. et al. p66Shc-generated oxidative signal promotes fat accumulation. J Biol Chem 283, 34283–34293 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ranieri S. C. et al. Mammalian life-span determinant p66shc A mediates obesity-induced insulin resistance. Proc Natl Acad Sci USA 107, 13420–13425 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Napoli C. et al. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 100, 2112–2116 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graiani G. et al. Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension 46, 433–440 (2005). [DOI] [PubMed] [Google Scholar]
- Zaccagnini G. et al. p66Shc A modulates tissue response to hindlimb ischemia. Circulation 109, 2917–2923 (2004). [DOI] [PubMed] [Google Scholar]
- Carpi A. et al. The cardioprotective effects elicited by p66Shc ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochim Biophys Acta 1787, 774–780 (2009). [DOI] [PubMed] [Google Scholar]
- Menini S. et al. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes 55, 1642–1650 (2006). [DOI] [PubMed] [Google Scholar]
- Cosentino F. et al. Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arterioscler Thromb Vasc Biol 28, 622–628 (2008). [DOI] [PubMed] [Google Scholar]
- Avogaro A., de Kreutzenberg S. V., Federici M. & Fadini G. P. The endothelium abridges insulin resistance to premature aging. J Am Heart Assoc 2, e000262 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirose K. & Liberman M. C. Lateral wall histopathology and endocochlear potential in the noise-damaged mouse cochlea. J Assoc Res Otolaryngol 4, 339–352 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hibino H. & Kurachi Y. Molecular and physiological bases of the K+ circulation in the mammalian inner ear. Physiology (Bethesda) 21, 336–345 (2006). [DOI] [PubMed] [Google Scholar]
- Nin F. et al. The endocochlear potential depends on two K+ diffusion potentials and an electrical barrier in the stria vascularis of the inner ear. Proc Natl Acad Sci USA 105, 1751–1756 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buckiova D., Popelar J. & Syka J. Aging cochleas in the F344 rat: morphological and functional changes. Exp Gerontol 42, 629–638 (2007). [DOI] [PubMed] [Google Scholar]
- Brown J. N., Miller J. M. & Nuttall A. L. Age-related changes in cochlear vascular conductance in mice. Hear Res 86, 189–194 (1995). [DOI] [PubMed] [Google Scholar]
- Nakashima T. et al. Disorders of cochlear blood flow. Brain Res Brain Res Rev 43, 17–28 (2003). [DOI] [PubMed] [Google Scholar]
- Picciotti P. M. et al. Vascular endothelial growth factor (VEGF) expression in noise-induced hearing loss. Hear Res 214, 76–83 (2006). [DOI] [PubMed] [Google Scholar]
- Fetoni A. R., Troiani D., Eramo S. L., Rolesi R. & Paludetti T. G. Efficacy of different routes of administration for Coenzyme Q10 formulation in noise-induced hearing loss: systemic versus transtympanic modality. Acta Otolaryngol 132, 391–399 (2012). [DOI] [PubMed] [Google Scholar]
- Fetoni A. R. et al. Rosmarinic acid up-regulates the noise-activated Nrf2/HO-1 pathway and protects against noise-induced injury in rat cochlea. Free Radic Biol Med 85, 269–281 (2015). [DOI] [PubMed] [Google Scholar]
- Berry A. et al. Greater resistance to inflammation at adulthood could contribute to extended life span of p66Shc−/− mice. Exp Gerontol 45, 343–350 (2010). [DOI] [PubMed] [Google Scholar]
- Tomilov A. A. et al. Decreased superoxide production in macrophages of long-lived p66Shc knock-out mice. J Biol Chem 285, 1153–1165 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shinohara T. et al. Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci USA 99(3), 1657–1660 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murray P. J. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6, 379–386 (2006). [DOI] [PubMed] [Google Scholar]
- Seidman M. D., Quirk W. S. & Shirwany N. A. Mechanisms of alterations in the microcirculation of the cochlea. Ann N Y Acad Sci 884, 226–232 (1999). [DOI] [PubMed] [Google Scholar]
- Shi X. Physiopathology of the cochlear microcirculation. Hear Res 282, 10–24 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Semenza G. L. Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 54, 17–28 (2003). [DOI] [PubMed] [Google Scholar]
- Riva C., Donadieu E., Magnan J. & Lavieille J. P. Age-related hearing loss in CD/1 mice is associated to ROS formation and HIF target proteins up-regulation in the cochlea. Exp Gerontol 42, 327–336 (2007). [DOI] [PubMed] [Google Scholar]
- Fetoni A. R., Picciotti P. M., Paludetti G. & Troiani D. Pathogenesis of presbycusis in animal models: a review. Exp Gerontol 46, 413–425 (2011). [DOI] [PubMed] [Google Scholar]
- Fetoni A. R. et al. Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: cochlear and cortical responses after an increase in antioxidant defense. J Neurosci 33, 4011–4023 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zheng Q. Y., Johnson K. R. & Erway L. C. Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 130, 94–107 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoshida N. & Liberman M. C. Sound conditioning reduces noise-induced permanent threshold shift in mice. Hear Res 148, 213–219 (2000). [DOI] [PubMed] [Google Scholar]
- Kujawa S. G. & Liberman M. C. Adding insult to injury: cochlear nerve degeneration after “temporary” noise-induced hearing loss. J Neurosci 29, 14077–14085 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Y., Hirose K. & Liberman M. C. Dynamics of noise-induced cellular injury and repair in the mouse cochlea. J Assoc Res Otolaryngol 3, 248–268 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dai M. & Shi X. Fibro-vascular coupling in the control of cochlear blood flow. PLos One 6, e20652 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang W. et al. Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of he intrastrial fluid-blood barrier. Proc Natl Acad Sci USA 109, 10388–10393 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- London N. R. & Gurgel R. K. The role of vascular endothelial growth factor and vascular stability in diseases of the ear. Laryngoscope 124, E340–E346 (2014). [DOI] [PubMed] [Google Scholar]
- Francia P. et al. Deletion of p66Shc gene protects against age-related endothelial dysfunction. Circulation 110, 2889–2895 (2004). [DOI] [PubMed] [Google Scholar]
- Medzhitov R. Origin and physiological roles of inflammation. Nature 454, 428–435 (2008). [DOI] [PubMed] [Google Scholar]
- Menardo J. et al. Oxidative stress, inflammation, and autophagic stress as the key mechanisms of premature age-related hearing loss in SAMP8 mouse Cochlea. Antioxid Redox Signal 16, 263–274 (2012). [DOI] [PubMed] [Google Scholar]
- Franceschi C. & Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69 Suppl 1, S4–S9 (2014). [DOI] [PubMed] [Google Scholar]
- Fetoni A. R., Piacentini R., Fiorita A., Paludetti G. & Troiani D. Water-soluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL). Brain Res 1257, 108–116 (2009). [DOI] [PubMed] [Google Scholar]
- Fetoni A. R. et al. In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig. Neuroscience 169, 1575–1588 (2010). [DOI] [PubMed] [Google Scholar]